Helixgate

Helixgate

Uncategorized

Insmed shelves Brinsupri in skin disease after mid-stage flop

Published

on

Insmed has given up on Brinsupri in the painful skin disorder hidradenitis suppurativa (HS) after a mid-stage trial failure. The company had ditched the pill in sinus inflammation at the end of last year.

The …

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

RFK Jr. says China is ‘eating our lunch’ in biotech advances

Published

on

China is “eating our lunch” on new drug approvals and clinical trial starts, HHS Secretary Robert F. Kennedy Jr. told Congress Tuesday, while praising the FDA’s actions so far.

“We are losing scientists, we’re losing …

Continue Reading

Uncategorized

Tortugas debuts with $106M and brain drugs from Hansoh, Eisai

Led by former Sage Therapeutics executives Jeff Jonas and Al Robichaud, the company is starting out with a portfolio of neurological medicines in clinical testing. 

Read More

Published

on

Led by former Sage Therapeutics executives Jeff Jonas and Al Robichaud, the company is starting out with a portfolio of neurological medicines in clinical testing. 

Read More

Continue Reading

Uncategorized

Merck’s Welireg combo fails in first-line kidney cancer

Published

on

Adding Merck’s Welireg to an existing Keytruda regimen didn’t lead to a significant improvement in newly diagnosed patients with advanced kidney cancer, Merck announced on Tuesday.

The results mark a setback …

Continue Reading
Advertisement

Trending